News
October 31, 2024
AbTherx and Gilead Expand Collaboration on Innovative Antibody Discovery Technologies
Expanded agreement includes development of additional transgenic mouse technologies and performance of additional therapeutic antibody research programs Foster City, ... Read More »
July 17, 2024
AbTherx Appoints Pallavi Tawde, PhD, as Head of Preclinical R&D...
Former Pfizer, BMS, and Denali scientific leader to lead expansion of antibody discovery, preclinical development, and early clinical capabilities Foster City, Calif.... Read More »
June 18, 2024
AbTherx Opens Antibody Discovery Technologies Research Center
New research center’s world-class antibody discovery capabilities support a growing portfolio of Atlas™ Mice transgenic technologies and partnerships Foster City, Cal... Read More »
May 9, 2024
The Jackson Laboratory and AbTherx Announce Partnership to Enhance Therapeutic...
Bar Harbor, Maine and Mountain View, California – May 9, 2024 – The Jackson Laboratory (JAX), an independent, nonprofit biomedical research organization, and AbTherx,... Read More »
March 20, 2024
AbTherx Appoints Jessica Stark, PhD, as Scientific Advisor
Glycoimmunology expert and co-inventor of AbLec technology joins AbTherx to expand expertise around challenging drug targets Mountain View, Calif. – March 20, 2024 – ... Read More »
